Tania S Burgert, MD

Trials

Studies that name Tania S Burgert, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:13 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT00845559 · The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

  Yale University · withdrawn · Obesity, Insulin Resistance, Impaired Glucose Tolerance · principal investigator
• Ph4
  NCT00846521 · Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity

  Yale University · terminated · Pediatric Obesity, Insulin Resistance, Impaired Glucose Tolerance · principal investigator
• Ph4
  NCT00667498 · Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance

  Yale University · completed · Pediatric Obesity, Insulin Resistance, Hyperinsulinemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Postprandial Glycemia in Association with Vascular Disease in Childhood Obesity
  K23DK074439 · NIDDK · YALE UNIVERSITY · PI TANIA S. BURGERT · fiscal years 2006 to 2008
  Named on NCT00846521